Evolution Worldwide of the Treatment of Patients with Advanced Diabetic Nephropathy by Renal Replacement Therapy

  • Anthony E. G. Raine


Of all the complications of diabetes mellitus, diabetic nephropathy is one of the most feared. The need for renal replacement therapy (RRT) itself imposes many burdens. Moreover, despite the now widespread availability of such treatment, the survival of patients with end stage renal disease remains disturbingly low [1], largely due to an excess of cardiovascular disease [2]. These problems have become increasingly clear over the past decade, as greater numbers of diabetic patients have entered dialysis and transplant programmes. In the past, access to RRT of patients with end stage diabetic nephropathy was restricted in Europe, particularly in those countries where limitations in resources for provision of RRT historically existed [3]. The dramatic and sustained growth in the availability and provision of this life saving treatment has led to worldwide increases in acceptance of diabetic patients for RRT; for example, it has grown from less than 2% of treated patients in Europe in 1974 [4] to over 10% in the mid-1980’s [5]. However, the proportion of RRT patients with diabetic nephropathy is much higher in other countries, notably the United States, where according to the United Stages Renal Data System (USRDS) approximately one third of all RRT patients have diabetic nephropathy, and the annual incidence of end stage renal failure in diabetic patients alone is over 40 per million population [6], compared with 3.6 per million in Europe in 1985 [5].


Diabetic Patient Diabetic Nephropathy Peritoneal Dialysis Renal Replacement Therapy Nephrol Dial Transplant 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Brunner FP and Seiwood NH. Results of renal replacement therapy in Europe, 1980–1987. Am J Kidney Dis 1990; 15: 384–396.PubMedGoogle Scholar
  2. 2.
    Brunner P and Selwood NH. Profile of patients on RRT in Europe and death rates due to major causes of death groups. Kidney Int 1992; 42: suppl. 38: S4–S15.Google Scholar
  3. 3.
    Joint Working Party on Diabetic Renal Failure of the BDA, the Renal Association and the Research Unit of the Royal College of Physicians. Renal failure in diabetes in the UK: Deficient provision of care in 1985. Diabetic Med 1988; 5: 79–84.CrossRefGoogle Scholar
  4. 4.
    Brunner FP, Giesecke B, Gurland HJ, et al. Combined report on regular dialysis and transplantation in Europe, V, 1974. Proc Euro Dial Transp Assoc 1976; 12: 2–64.Google Scholar
  5. 5.
    Brunner FP, Brynger H, Challah S, et al. Renal replacement therapy in patients with diabetic nephropathy, 1980–85. Nephrol Dial Transplant 1988; 3: 585–595.PubMedGoogle Scholar
  6. 6.
    Held PJ, Port FK, Blagg CR, Agodoa LYC. United States Renal Data System 1990 annual report. Am J Kidney Dis 1990; suppl. 2: 1–106.Google Scholar
  7. 7.
    Raine AEG, Margreiter R, Brunner FP, et al. Report on management of renal failure in Europe, XXII. Nephrol Dial Transplant 1992; 7: suppl. 2: 7–35.PubMedGoogle Scholar
  8. 8.
    Raine AEG. Epidemiology, development and treatment of end stage renal failure in non-insulin dependent diabetics in Europe. Diabetologia 1993; 36: 1099–1104.PubMedCrossRefGoogle Scholar
  9. 9.
    Jarrett RJ. The epidemiology of diabetes mellitus. In: Pickup J, Williams G (eds). Textbook of Diabetes, vol 1. Oxford: Blackwell Scientific Publications; 1991; pp 47–56.Google Scholar
  10. 10.
    United States Renal Data System 1991 Annual Data Report. Incidence and causes of treated ESRD. Am J Kidney Dis 1991; 17: suppl. 2: 30–37.Google Scholar
  11. 11.
    The 1993 USRDS Annual Data Report. Incidence and causes of treated ESRD. Am J Kidney Dis 1993; 22: suppl. 2: 38–45.Google Scholar
  12. 12.
    US Renal Data System, USRDS 1992 Annual Data Report. The National Institutes of Health, Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases; August 1992.Google Scholar
  13. 13.
    Canadian Organ Replacement Register, 1991 Annual Report. Don Mills, Ontario: Hospital Medical Records Institute; April 1993.Google Scholar
  14. 14.
    Fabre J, Balant LP, Dayer PG, et al. The kidney in maturity onset diabetes mellitus: a clinical study of 510 patients. Kidney Int 1982; 21: 730–738.PubMedCrossRefGoogle Scholar
  15. 15.
    Hasslacher C, Ritz E, Wahl P, Michael C. Similar risks of nephropathy in patients with type I and type II diabetes mellitus. Nephrol Dial Transplant 1989; 4: 859–863.PubMedGoogle Scholar
  16. 16.
    Stephen SGW, Gillaspry JA, Clyne D, Mejia A, Pollok VE. Racial differences in the incidence of end stage renal disease in type I and type II diabetes mellitus. Am J Kidney Dis 1990; 15: 562–567.Google Scholar
  17. 17.
    Ritz E, Nowack R, Fliser D, et al. Type II diabetes mellitus: is the renal risk adequately appreciated? Nephrol Dial Transplant 1991; 6: 679–682.PubMedCrossRefGoogle Scholar
  18. 18.
    Catalano C, Postorino M, Kelly PJ, et al. Diabetes mellitus and renal replacement therapy in Italy: prevalence, main characteristics and complications. Nephrol Dial Transplant 1990; 5: 788–796.PubMedCrossRefGoogle Scholar
  19. 19.
    Cowie CC, Port FK, Wolfe RA, et al. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med 1989; 321: 1074–1079.PubMedCrossRefGoogle Scholar
  20. 20.
    Geerlings W, Tufveson G, Brunner FP, et al. Combined report on regular dialysis and transplantation in Europe, XXI, 1990. Nephrol Dial Transplant 1991; 6: suppl. 4: 5–28.Google Scholar
  21. 21.
    Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–986.CrossRefGoogle Scholar
  22. 22.
    Lewis EJ, Hunsickler LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456–1462.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Anthony E. G. Raine

There are no affiliations available

Personalised recommendations